Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines
2022 · Nature Communications · 50 citations
https://doi.org/10.1038/s41467-022-29224-5
L
Luay Aswad
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
423
Citations
7
h-index
6
i10-index
Luay Aswad is an academic researcher from Science for Life Laboratory. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Epigenetics and DNA Methylation & Genomics and Chromatin Dynamics. The author has an h-index of 7, co-authored 12 publications.
ORCID: 0000-0002-8730-9208Papers by this author
worksMicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
2019 · Scientific Reports · 42 citations
https://doi.org/10.1038/s41598-019-49155-4
AlphaFold with conformational sampling reveals the structural landscape of homorepeats
2024 · Structure · 4 citations
https://doi.org/10.1016/j.str.2024.08.016
TP63, SOX2 and KLF5 Establish Core Regulatory Circuitry and Construct Cancer Specific Epigenome in Esophageal Squamous Cell Carcinoma
2019 · bioRxiv (Cold Spring Harbor Laboratory) · 3 citations
https://doi.org/10.1101/825372
Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia
2024 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-024-54400-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat